(Q41073796)

English

An evaluation of the effectiveness and safety of razoxane when used as an adjunct to surgery in colo-rectal cancer. Report of a controlled randomised study of 603 patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

An evaluation of the effectiveness and safety of razoxane when used as an adjunct to surgery in colo-rectal cancer. Report of a controlled randomised study of 603 patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

author name string

R D Kingston

1

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

J W Fielding

2

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

M K Palmer

3

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 July 1993

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

International Journal of Colorectal Disease

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

106-110

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

https://scigraph.springernature.com/pub.10.1007/bf00299338

0 references

Adjuvant oral razoxane (ICRF-159) in resectable colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8409683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Razoxane for Crohn's colitis and non-specific proctitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8409683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leukaemia in psoriatic patients treated with razoxane

1 reference

https://pubmed.ncbi.nlm.nih.gov/8409683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphoma and leukaemia due to drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/8409683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of leukaemia associated with cancer chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8409683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://pubmed.ncbi.nlm.nih.gov/8409683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of Metastatic Spread by I.C.R.F. 159: Selective Deletion of a Malignant Characteristic

1 reference

https://pubmed.ncbi.nlm.nih.gov/8409683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of oral adjuvant razoxane (ICRF 159) in resectable colorectal cancer: five-year follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/8409683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8409683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of prophylactic castration in the therapy of human mammary cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8409683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peri-operative heparin: a possible adjuvant to surgery in colo-rectal cancer?

1 reference

https://pubmed.ncbi.nlm.nih.gov/8409683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Razoxane: a review of 6 years' therapy in psoriasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8409683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metastases and the normalization of tumour blood vessels by ICRF 159: a new type of drug action

1 reference

https://pubmed.ncbi.nlm.nih.gov/8409683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Control of Malignant Metastases by ICRF 159

1 reference

https://pubmed.ncbi.nlm.nih.gov/8409683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of ICRF-159 in patients with metastatic colorectal carcinoma previously exposed to systemic chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8409683

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00299338

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41073796&oldid=1914572209"